Company Search:
Advanced Search
Sponsored Links
Conatus Pharmaceuticals Inc Company Snapshot
Conatus Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Conatus Pharmaceuticals Inc with three other companies in this sector in the United States: Abeona Therapeutics Inc (2016 sales of $889,000.00 ), Cyclacel Pharmaceuticals, Inc. ($843,000.00 of which 100% was Pharmaceutical Products), and Pulmatrix Inc ($835,000.00 ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Conatus Pharmaceuticals Inc
  Stock Performance Chart for Conatus Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/10/2017): 4.22
(Figures in U.S. Dollars)
1 Week -5.0%   13 Weeks -19.9%  
4 Weeks -19.5%   52 Weeks 105.9%  
Conatus Pharmaceuticals Inc Key Data:
  Ticker: CNAT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 799,046
(Year Ending Jan 2017).
Employees: 15
  Currency: U.S. Dollars Market Cap: 126,623,050
  Fiscal Yr Ends: December Shares Outstanding: 30,005,462
  Share Type: Common Closely Held Shares: 1,024,277
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.